These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34609459)

  • 1. US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer.
    Haghighat S; Sussman DA; Deshpande A
    JAMA; 2021 Oct; 326(13):1328. PubMed ID: 34609459
    [No Abstract]   [Full Text] [Related]  

  • 2. US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer-Reply.
    Barry MJ; Davidson K; Mangione CM
    JAMA; 2021 Oct; 326(13):1328-1329. PubMed ID: 34609456
    [No Abstract]   [Full Text] [Related]  

  • 3. US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty.
    Ng K; May FP; Schrag D
    JAMA; 2021 May; 325(19):1943-1945. PubMed ID: 34003238
    [No Abstract]   [Full Text] [Related]  

  • 4. USPSTF colorectal cancer screening update 2021: A review of evidence.
    Klimkiewicz P
    Nurse Pract; 2022 Dec; 47(12):37-42. PubMed ID: 36399147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.
    Bretthauer M; Kaminski MF; Hassan C; Kalager M; Holme Ø; Hoff G; Løberg M; Regula J; Castells A; Adami HO
    Ann Intern Med; 2017 Jan; 166(2):139-140. PubMed ID: 27820949
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Constitutes Evidence? Colorectal Cancer Screening and the U.S. Preventive Services Task Force.
    Lerner BH; Curtiss-Rowlands G
    J Gen Intern Med; 2022 Aug; 37(11):2855-2860. PubMed ID: 35428902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FAR; Gillman MW; Harper DM; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Owens DK; Phillips WR; Phipps MG; Pignone MP; Siu AL
    JAMA; 2016 Jun; 315(23):2564-2575. PubMed ID: 27304597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same….
    Ito Fukunaga M; Wiener RS; Slatore CG
    JAMA Oncol; 2021 May; 7(5):684-686. PubMed ID: 33687430
    [No Abstract]   [Full Text] [Related]  

  • 10. In high-risk adults aged 50 to 80 y, USPSTF recommends annual lung cancer screening with LDCT (moderate certainty).
    Lim LS
    Ann Intern Med; 2021 Aug; 174(8):JC86. PubMed ID: 34339228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reanalysis of All-Cause Mortality in the U.S. Preventive Services Task Force 2016 Evidence Report on Colorectal Cancer Screening.
    Swartz AW; Eberth JM; Josey MJ; Strayer SM
    Ann Intern Med; 2017 Oct; 167(8):602-603. PubMed ID: 28828493
    [No Abstract]   [Full Text] [Related]  

  • 12. Why Was the US Preventive Services Task Force's 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis.
    Lerner BH; Curtiss-Rowlands G
    Milbank Q; 2022 Sep; 100(3):702-721. PubMed ID: 36148791
    [No Abstract]   [Full Text] [Related]  

  • 13. The US Preventive Services Task Force Recommendation on Lung Cancer Screening.
    Squires BS; Levitin R; Grills IS
    JAMA; 2021 Aug; 326(5):440-441. PubMed ID: 34342624
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
    Swartz AW; Eberth JM; Strayer SM
    Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The US Preventive Services Task Force Recommendation on Lung Cancer Screening-Reply.
    Barry MJ; Davidson K; Mangione CM
    JAMA; 2021 Aug; 326(5):441. PubMed ID: 34342622
    [No Abstract]   [Full Text] [Related]  

  • 16. The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    Ornello R; Pistoia F; Sacco S
    JAMA; 2021 Jul; 326(1):89. PubMed ID: 34228071
    [No Abstract]   [Full Text] [Related]  

  • 17. The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    Poorthuis MHF; de Borst GJ
    JAMA; 2021 Jul; 326(1):88-89. PubMed ID: 34228070
    [No Abstract]   [Full Text] [Related]  

  • 18. The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis.
    Wolters FJ; Volovici V
    JAMA; 2021 Jul; 326(1):88. PubMed ID: 34228069
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.
    Schaeffer EM
    J Urol; 2020 Oct; 204(4):859-860. PubMed ID: 32703066
    [No Abstract]   [Full Text] [Related]  

  • 20. The US Preventive Services Task Force Recommendation Statement About Screening Asymptomatic Adults for Carotid Stenosis-Reply.
    Barry MJ; Davidson K; Mangione CM
    JAMA; 2021 Jul; 326(1):89-90. PubMed ID: 34228067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.